{"organizations": [], "uuid": "6e1791a83d3030ca3035fd3acabd5e396b766279", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180307.html", "section_title": "Archive News &amp; Video for Wednesday, 07 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biotime-announces-dsmb-approval-to/brief-biotime-announces-dsmb-approval-to-proceed-to-cohort-4-of-the-opregen-clinical-trial-idUSASB0C96C", "country": "US", "domain_rank": 408, "title": "BRIEF-BioTime Announces DSMB Approval To Proceed To Cohort 4 Of The OpRegen Clinical Trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.995, "site_type": "news", "published": "2018-03-07T21:25:00.000+02:00", "replies_count": 0, "uuid": "6e1791a83d3030ca3035fd3acabd5e396b766279"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biotime-announces-dsmb-approval-to/brief-biotime-announces-dsmb-approval-to-proceed-to-cohort-4-of-the-opregen-clinical-trial-idUSASB0C96C", "ord_in_thread": 0, "title": "BRIEF-BioTime Announces DSMB Approval To Proceed To Cohort 4 Of The OpRegen Clinical Trial", "locations": [], "entities": {"persons": [{"name": "egen", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biotime", "sentiment": "negative"}, {"name": "biotime inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7 (Reuters) - Biotime Inc:\n* BIOTIME ANNOUNCES DSMB APPROVAL TO PROCEED TO COHORT 4 OF THE OPREGENÂ® CLINICAL TRIAL Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T21:25:00.000+02:00", "crawled": "2018-03-08T17:10:40.023+02:00", "highlightTitle": ""}